Defensive diagnostics revisited | Dementia radiotracer extends reach | Imaging industry newsmakers

Contradicting prior research connecting heavy ordering of diagnostic exams with fear of malpractice charges—aka “defensive medicine”—a new survey shows ED referrers more focused on not harming patients than on not getting sued.

An established radiopharmaceutical can now be applied with the FDA’s blessing when symptoms of cognitive decline point to the second most common form of degenerative dementia (after only Alzheimer’s disease).  

Siemens Healthineers announces restructuring of diagnostics division to save approximately 300 million euros ($302 million) each year as of 2025.

With its 108th scientific assembly and annual meeting a little more than two weeks away, the Radiological Society of North America is encouraging attendees to experience 2022’s big show virtually—even if they’ll be there in person.

Emergency departments that employ nonphysician practitioners probably improve patient access to timely care. However, these EDs also order 5.3% more imaging than their physician-only counterparts.

RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.

The American Roentgen Ray Society (ARRS), Strategic Radiology and Bracco Diagnostics have separately elevated early- and mid-career radiologists to heightened educational opportunities.

And the method does not come at the expense of diagnostic yield, an uptick in adverse events or increased procedure times.

The Centers for Medicare and Medicaid Services (CMS) is charging forward with its plan to bring Medicare and Medicaid beneficiaries into coordinated care models.

FDA Commissioner Robert Califf, MD, who is a cardiologist, spoke at the opening session of the American Heart Association about the need to step up and address two major problems in the American healthcare system.